References in periodicals archive ?
Merck, known as MSD outside the United States and Canada, today announced an expansion of the MECTIZAN Donation Program (MDP) to reach up to an additional 100 million people per year through 2025 as part of the global effort to eliminate lymphatic filariasis (LF).
The Fund is supported by in-kind contributions from GlaxoSmithKline plc, which will donate albendazole treatments over the next ten years to eliminate lymphatic filariasis and deworm school-age children in target countries, and MSD, which will donate ivermectin to eliminate lymphatic filariasis and river blindness through the Mectizan Donation Program, with co-investments from the UK Department for International Development (DfID) and United States Agency for International Development (USAID).
It will be administered through the MECTIZAN Donation Program (MDP), a public/private partnership.
One of the main factors contributing to the increase was in-kind gifts of Mectizan tablets, a medication used to treat river blindness.
51-56) These included the following: (i) Establishment of a standard protocol for diagnosis for LF; (ii) Vector control; (iii) Community directed distribution of long lasting insecticide treated bed-net (LLN) and Mectizan (Mass chemotherapy)/health education; (iv) Integrated control policy (onchocerciasis, schistosomiasis, and LF); and (v) Establishment of policy monitoring/evaluation (feedback mechanism)/with training and capacity building.
The Mectizan Donation Program: 20 Years of Successful Collaboration--a Retrospective.
It commemorates the 2 5th anniversary of Merck's Mectizan Donation Program which started in 1987--the longest-running initiative and public-private partnership of its kind--to treat millions in African and South American countries who suffered from the parasitic disease river blindness.
Merck first announced that it would donate Mectizan to all who needed it for as long as necessary until the disease was eliminated in October 1987.
Once the baseline studies were carried out, the National Onchocerciasis Elimination Program, lead by the National Institute of Health of Colombia, with technical and financial support from the Onchocerciasis Elimination Program for the Americas (OEPA), began the mass drug administration (MDA) of ivermectin (Mectizan*) donated by Merck through the Mectizan Donation Program.
In business, students can review case studies not only for the value of business decisions to shareholders, but also for the value of business decisions to society, as in the case of CEOing river-blindness, Mectizan, on which the company only could lose money.
It is sold under brand names Stromectol in the United States, Ivomec in Europe by Merial Animal Health, Mectizan in Canada by Merck and Ivexterm in Mexico by Valeant Pharmaceuticals International.
An African community can be protected against river blindness by the distribution of the drug Mectizan with a donation of pounds 19.
Medical browser ?
- meconial colic
- meconic acid
- meconium aspiration
- meconium aspiration syndrome
- meconium blockage syndrome
- meconium ileus
- meconium periorchitis
- meconium peritonitis
- meconium plug
- meconium plug syndrome
- meconium stained amniotic fluid
- meconium staining
- meconium-stained amniotic fluid
- Med 3
- Med 4
- Med 5
- MED scope
- Med Tech
- MEDAC syndrome
- Medawar Peter Brian
- Medawar, Sir Peter Brian
- medazepam HCl
- Medea complex
- Médecins sans Frontières
- Med-E-Jet inoculator
Full browser ?
- Mecoscale and Microscale Dynamics Group
- Mecosta County
- Mecosta County General Hospital
- Mecosta County, MI
- Mecosta County, Michigan
- Mecosta-Osceola Area Resource Center
- Mecosta-Osceola Intermediate School District
- Mecula communicans
- Med 3
- Med 4
- Med 5
- Med Adm C
- Med AIL
- Med Andra Ord
- Med ball
- MED BDE
- MED ED